Investment Analysts’ Updated EPS Estimates for October, 17th (ALV, APTV, ARWR, BIO, CLX, CYTK, EDRY, HSTM, JNJ, KMB)

Investment Analysts’ updated eps estimates for Wednesday, October 17th:

Autoliv (NYSE:ALV) had its market perform rating reissued by analysts at Wells Fargo & Co. Wells Fargo & Co currently has a $91.00 price target on the stock, down from their previous price target of $113.00.

Aptiv (NYSE:APTV) had its outperform rating reiterated by analysts at Wells Fargo & Co. They currently have a $106.00 price target on the stock, down from their previous price target of $111.00.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its outperform rating reaffirmed by analysts at William Blair.

Goldman Sachs Group Inc started coverage on shares of Bio-Rad Laboratories (NYSE:BIO). Goldman Sachs Group Inc issued a buy rating on the stock.

Clorox (NYSE:CLX) had its market perform rating reissued by analysts at Wells Fargo & Co. They currently have a $145.00 price target on the stock, up from their previous price target of $135.00.

Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at Cantor Fitzgerald. They currently have a $14.00 target price on the stock. The analysts wrote, “We reiterate our OW rating and 12-month price target of $14. CYTK hosted a R&D Day during which it provided incremental updates on its programs and broadening pipeline. Takeaways include design of the second P3 study of ome’ called METEORIC-HF, which we are enthusiastic to see as it will evaluate exercise tolerance in patients with HF. METEROIC data are expected in 2021, and we believe a positive outcome would brightline the differentiated clinical profile vs. current SOC. Additionally, data from the primary study for regulatory purposes, GALACTIC-HF, are expected in 2021, with interim reads in 2019 (futility) and 2020 (efficacy) that may yield milestone payments to the company.””

EuroDry (NASDAQ:EDRY) had its buy rating reiterated by analysts at Maxim Group. The firm currently has a $13.00 target price on the stock. The analysts wrote, “EuroDry announced a successful refinancing of its credit facilities, increasing liquidity by $8M and pushing out maturities to 2022–2025. With the refinancings in the rear view, we expect the company to turn its attention to fleet expansion and/or redeeming the Series B Preferred Shares.””

HealthStream (NASDAQ:HSTM) had its hold rating reiterated by analysts at Barrington Research. The analysts wrote, “We expect HealthStream to report Q3/18 revenue of $58.7 million, which is 1% greater than the FactSet consensus of $58.3 million. Our revenue forecast represents a year-over-year decline of 8% and a sequential increase of 3%. Solutions (PES) business, which was divested in February 2018, our revenue forecast calls for year-over-year growth of 7%.””

Johnson & Johnson (NYSE:JNJ) had its buy rating reiterated by analysts at HC Wainwright.

Kimberly Clark (NYSE:KMB) had its market perform rating reiterated by analysts at Wells Fargo & Co. The firm currently has a $105.00 target price on the stock, up from their previous target price of $97.00.

JMP Securities started coverage on shares of KKR Real Estate Finance Trust (NYSE:KREF). JMP Securities issued an outperform rating on the stock.

Lam Research (NASDAQ:LRCX) had its overweight rating reiterated by analysts at KeyCorp. The firm currently has a $231.00 target price on the stock, down from their previous target price of $261.00.

Magna International (NYSE:MGA) (TSE:MG) had its outperform rating reissued by analysts at Wells Fargo & Co. They currently have a $66.00 target price on the stock, down from their previous target price of $73.00.

Merck KGaA (FRA:MRK) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

PTC (NASDAQ:PMTC) had its outperform rating reiterated by analysts at Wedbush. They currently have a $112.00 target price on the stock.

Primo Water (NASDAQ:PRMW) had its buy rating reaffirmed by analysts at Barrington Research. They currently have a $21.00 price target on the stock. The analysts wrote, “We are currently expecting third quarter revenue of $83.3 million. Management’s guidance for Primo’s top-line performance in the third quarter is $80.5- 83.5 million. The consensus estimate is $83.1 million. Our top-line estimate includes $72.4 million in water-related sales (both exchange and refill) versus the $71.7 million generated in last year’s comparable period and $10.9 million in dispenser sales versus the $10.5 million in revenue delivered in Q3/17.””

Spectrum Brands (NYSE:SPB) had its market perform rating reiterated by analysts at Wells Fargo & Co. The firm currently has a $75.00 target price on the stock, down from their previous target price of $85.00.

Goldman Sachs Group Inc initiated coverage on shares of BIO-TECHNE (NASDAQ:TECH). The firm issued a neutral rating on the stock.

Tenneco (NYSE:TEN) had its market perform rating reaffirmed by analysts at Wells Fargo & Co. They currently have a $45.00 price target on the stock, down from their previous price target of $50.00.

Tractor Supply (NASDAQ:TSCO) had its overweight rating reissued by analysts at Piper Jaffray Companies. They currently have a $102.00 target price on the stock.

Takkt (ETR:TTK) had its neutral rating reissued by analysts at DZ Bank AG.

Visteon (NYSE:VC) had its market perform rating reiterated by analysts at Wells Fargo & Co. They currently have a $86.00 price target on the stock, down from their previous price target of $123.00.

Receive News & Ratings for Autoliv Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autoliv Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply